ArticleBMC gastroenterology2025
Impact of venous thromboembolism on mortality in hospitalized patients with inflammatory bowel disease: analysis of the MIMIC-IV database, 2008 to 2022.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inpatient Outcomes of Pulmonary Embolism in Patients with Inflammatory Bowel Disease: Insights from a Nationwide Analysis.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInflammatory bowel disease (IBD)is associated with extraintestinal manifestations, notably venous thromboembolism (VTE), a major cause of morbidity and mortality. Patients with IBD have a 2- to 4-fold increased risk of VTE compared to the general population. Large-scale studies examining associations between VTE and adverse outcomes in hospitalized IBD patients are limited. This study aimed to investigate associations between VTE and mortality (in-hospital and overall) in hospitalized patients with IBD.
methodsThis retrospective cohort study included the data of 2790 adults hospitalized with IBD extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) v.3.1 Database, 2008 to 2022. IBD diagnosis was determined using ICD-9 and-10 codes. Main study outcomes were in-hospital and overall mortality. Covariates were demographic data, laboratory results, comorbidities, and hospital stays. Logistic regression and Cox proportional hazards models were used to evaluate associations between VTE and mortality, adjusting for confounders.
resultsHospitalized patients with IBD who had VTE were significantly older and had lower hemoglobin, RBC count, and sodium levels, and higher Charlson Comorbidity Index (CCI) scores. The VTE group also had significantly longer hospital stays (P < 0.001), higher in-hospital mortality (10.26% vs. 2.28%, P < 0.001), and overall mortality (34.19% vs. 16.01%, P < 0.001). Cox regression analysis showed that VTE was an independent predictor of in-hospital mortality (aHR 2.205, P = 0.021). Long‑term mortality remained significantly higher in the VTE cohort (aHR 1.758, P = 0.001).
conclusionVTE is an independent predictor of in-hospital and long-term mortality in hospitalized patients with IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.